AstraZeneca on Thursday said it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, raising ...
AstraZeneca (AZN) stock rises as its Q4 results which exceeded Street forecasts address concerns over its China investigation ...
A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...
A malaria vaccine developed by members of the University of Oxford team behind the AstraZeneca COVID-19 jab ... of 409 children who received a fourth booster dose at one year, with either a ...
Pascal Soriot, chief executive of AstraZeneca, says his company has ‘very good collaboration’ with the Government and remains committed to investing in the UK - Zach Gibson/Bloomberg The boss ...
AstraZeneca canceled its £450 million vaccine manufacturing plant in Liverpool after rejecting a £78 million government funding offer. The company raised concerns over NHS drug pricing policies ...
Science Minister Sir Chris Bryant has revealed that a proposed investment deal between the Government and AstraZeneca will not proceed as it did not "add up for the UK taxpayer". He expressed to ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In late November 2023 AstraZeneca’s chief executive Pascal Soriot flew from Sydney to London to deliver a ...
AstraZeneca's shares plunged after the news of Wang's detention, wiping about $18 billion off the company's value. They have since recovered and are up about 10% this year, including today's gains.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results